Tag: Lourido Lab

Whitehead Fellow Sebastian Lourido

Whitehead Fellow Sebastian Lourido speaks about proposed budget cuts

March 17, 2017

The budget proposed on March 15, 2017 would cut National Institutes of Health funding by an estimated 20 percent.

Sebastian Lourido appointed as a Member of Whitehead Institute and of the faculty of Massachusetts Institute of Technology

January 18, 2017

An emerging leader in investigations on deadly parasitic infections, Lourido’s appointment will further enhance one of the world’s most accomplished biomedical research institutes

Images of toxoplasma parasites inside of a host cell

Genome-wide Toxoplasma screen reveals mechanisms of parasitic infections

September 1, 2016

Whitehead Institute researchers have conducted the first genome-wide screen in Apicomplexa, a phylum of single-celled parasites that cause diseases such as malaria and toxoplasmosis. The screen sheds light into the vast, unstudied reaches of parasite genomes, uncovering for instance a protein common to all apicomplexans.

Illustration of DNA helices in tubes

Engineers design programmable RNA vaccines against Ebola, influenza

July 4, 2016

MIT and Whitehead Institute scientists have developed a new type of easily customizable vaccine that can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks. So far, they have designed vaccines against Ebola, H1N1 influenza, and Toxoplasma gondii (a relative of the parasite that causes malaria), which were 100 percent effective in tests in mice.

Three images of human lung cells were infected with influenza A virus.

Tiny alpaca-derived antibodies point to targets preventing viral infection

June 20, 2016

Using tiny, alpaca-derived, single-domain antibody fragments, Whitehead Institute scientists have developed a method to perturb cellular processes in mammalian cells, allowing them to tease apart the roles that individual proteins play in these pathways. With improved knowledge of protein activity, scientists can better understand not only basic biology but also how disease corrupts cellular function and identify potential therapeutics to rectify these aberrations.

Diagram of CDPK1 in its active and inactive forms

Tiny antibodies point to vulnerability in disease-causing parasites

August 24, 2015

By teasing apart the structure of an enzyme vital to the parasites that cause toxoplasmosis and malaria, Whitehead Institute scientists have identified a potentially ‘drugable’ target that could prevent parasites from entering and exiting host cells.

Photo: David Pincus and Sebastian Lourido

Two Whitehead Fellows snag prestigious NIH Early Independence Awards

September 30, 2013

Whitehead Fellows Sebastian Lourido and David Pincus have each been named a recipient of a 2013 National Institutes of Health (NIH) Director’s Early Independence Award, aimed at accelerating the careers of exceptionally creative junior scientists.

© Whitehead Institute for Biomedical Research              455 Main Street          Cambridge, MA 02142